Clinical Trial Update: A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness [Phase 3]

View source ↗

Summary

Phase 3 within-subject trial evaluating the efficacy and safety of Diclofenac Sodium Topical Gel 1% vs placebo in subjects with delayed onset muscle soreness; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed-onset Muscle Soreness

Drugs mentioned

• diclofenac sodium topical gel, 1% (diclofenac sodium topical gel, 1%)

Snippet

Sponsor: Novartis | Conditions: Muscle Soreness | Phase 3 | Status: COMPLETED | Results posted: 2016-04-05